Developments March Novavax to sell $38mm equity offering Praecis Pharma in technology transfer with Gilead Class action brought against Northfield Labs Medicis strikes distribution deal for Reloxin BioMarin to sell common stock and convertible debt Curis restates its financials; Delays 10-K North American Scientific gets [more...]
Summary Covers collaborations and licensing deals involving biotech companies Collaborations announced 2008 Vivus and Deerfield Management provide funds for the phase 3 program for avanafil, a fast-acting, highly [more...]
Secondary Offerings Onyx Pharmaceuticals $20 million common stock offering Prospectus supplement 11.14.05 Common stock shelf registration Form S-3 1.20.05 Cooley Godward opinion Idenix Pharmaceuticals $150 million common stock offering Priced 10.26.05 Form 8-K summary Underwriting agreement (Morgan Stanley) Wilmer Cutler legal opinion [more...]
2007 Financings Exelixis $30mm loan facility Form 8-K 12.21.07 Loan and security agreement eighth amendment 12.21.08 Osiris Therapeutics $12mm private placement and common stock conversion Press release 12.20.07 Convertible promissory note conversion agreement 12.19.07 Titan Pharmaceuticals $21.3mm private placement [more...]
Jazz Pharmaceuticals $108mm IPO Neurology and psychiatry Business Company website News - stock chart JAZZ Prospectus Final prospectus 5.31.07 Term sheet FWP SEC filings EDGAR filings page EDGAR filed exhibits Exhibit index Scroll to bottom 3.09.07 3.27.07 4.20.07 5.17.07 [more...]
Agilent / Stratagene Cash merger Life science research and diagnostic products Background of the merger Advisors Agilent: Stratagen: Houlihan Lokey Announced 4.06.07 Press release Form 8-K Closed 6.07.07 Form 15 Form 8-K Agreements Form 8-K Merger agreement Voting agreement Asset purchase agreement License agreement Proxy [more...]